Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors
about
Methamphetamine and the hypothalamic-pituitary-adrenal axisChronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging.Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment StudySex Differences in the Reinstatement of Methamphetamine Seeking after Forced Abstinence in Sprague-Dawley Rats.Addiction and treatment experiences among active methamphetamine users recruited from a township community in Cape Town, South Africa: A mixed-methods studyPredictors of time to relapse in amphetamine-type substance users in the matrix treatment program in Iran: a Cox proportional hazard model application.Impact of an exercise intervention on methamphetamine use outcomes post-residential treatment care.Illicit drug use in acute care settings.Altered Statistical Learning and Decision-Making in Methamphetamine Dependence: Evidence from a Two-Armed Bandit Task.Can persons with a history of multiple addiction treatment episodes benefit from technology delivered behavior therapy? A moderating role of treatment history at baseline.Relapse and Risk-taking among Iranian Methamphetamine Abusers Undergoing Matrix Treatment ModelThe cortisol level and its relationship with depression, stress and anxiety indices in chronic methamphetamine-dependent patients and normal individuals undergoing inguinal hernia surgery.Single nucleotide polymorphism near CREB1, rs7591784, is associated with pretreatment methamphetamine use frequency and outcome of outpatient treatment for methamphetamine use disorder.Neuropsychological comparisons of cocaine versus methamphetamine users: a research synthesis and meta-analysis.Role of microglia in methamphetamine-induced neurotoxicity.The relationship between the UPPS-P impulsive personality traits and substance use psychotherapy outcomes: A meta-analysis.N-acetyl cysteine reverses bio-behavioural changes induced by prenatal inflammation, adolescent methamphetamine exposure and combined challenges.The neurobiological mechanisms of physical exercise in methamphetamine addiction.Selective activation of striatal NGF-TrkA/p75NTR/MAPK intracellular signaling in rats that show suppression of methamphetamine intake 30 days following drug abstinence.Critical considerations in responding to crystal methamphetamine use in Australian Aboriginal communities.Tulsa 1000: a naturalistic study protocol for multilevel assessment and outcome prediction in a large psychiatric sample.Impulsivity predicts poorer improvement in quality of life during early treatment for people with methamphetamine dependence.Working memory predicts methamphetamine hair concentration over the course of treatment: moderating effect of impulsivity and implications for dual-systems model.Ifenprodil Attenuates Methamphetamine-Induced Behavioral Sensitization and Activation of Ras-ERK-∆FosB Pathway in the Caudate Putamen.Abstinence to chronic methamphetamine switches connectivity between striatal, hippocampal and sensorimotor regions and increases cerebral blood volume response.Craving Responses to Methamphetamine and Sexual Visual Cues in Individuals With Methamphetamine Use Disorder After Long-Term Drug Rehabilitation.Alexithymia in Young Adults With Substance Use Disorders: Critical Issues About Specificity and Treatment Predictivity.
P2860
Q30409436-D09ACB41-AE00-46B1-B5D0-00E12D818374Q30873118-782758A0-4B97-4BC7-B117-1CBA3F40567CQ35532106-90C00E70-DC1C-45FF-BF9F-86F03C314883Q35819948-7918F848-9175-4A6C-B1E2-E3992151E84AQ35841679-6DE066CA-C768-4950-8650-9173174DCB45Q36085088-A4CB39ED-5FB5-48F0-8F05-E0F919B0DA6CQ36249047-FF1C0BF1-21D3-4C66-89AA-EB540EA8099CQ36258133-A3545375-DBB7-4C6E-8757-64DCE6AB8B1EQ36381733-51939EF5-CECB-476B-AFC9-10C791B8F5E7Q36463680-3492133D-CBB5-4253-981D-7D967D05F6A5Q36812920-D8FEB721-B1B1-4226-95B8-15E6437902ACQ37216671-2461E8F7-AAA2-4414-BE80-6E8B9399EB8FQ37316136-99783756-B0CD-4D53-B712-8BE27FC19198Q38616220-8688BAFD-3D71-4FAF-B933-F9F49E665D6EQ39427179-2ECF3CBF-980F-44A7-B655-A4BFBC2E5B9DQ39435513-E37C063B-B81E-4D5A-BF73-4A6F02B7B452Q46265873-D97506D1-1D1A-4338-9082-A2BAEB2C0AC6Q47268750-DEE34ED8-8191-4075-8E08-143258FE982FQ47374044-8ADB9286-750A-4945-B337-EECEC61EB077Q47394318-D2E6E993-17E7-4B4A-AA57-4F6F76A32247Q47551793-ACD66180-6C98-407E-AA68-BF71529D8887Q47664040-0D30CFE6-27DA-4CCC-819A-A582831D6F34Q48345861-76DFF196-F3C5-404A-BCCF-21F2D6020A2DQ48658295-84DC3946-3E52-421D-8BE3-C2D1BD356989Q52666567-05FA7335-4C82-4B3C-8F82-3983E3D5C122Q54986412-0C54705C-C3F9-4013-B9C9-1CC60D997A43Q55044318-CD8E8119-C900-438F-A06F-D2A7222139EE
P2860
Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Time to relapse following trea ...... ive on patterns and predictors
@ast
Time to relapse following trea ...... ive on patterns and predictors
@en
type
label
Time to relapse following trea ...... ive on patterns and predictors
@ast
Time to relapse following trea ...... ive on patterns and predictors
@en
prefLabel
Time to relapse following trea ...... ive on patterns and predictors
@ast
Time to relapse following trea ...... ive on patterns and predictors
@en
P2860
P1476
Time to relapse following trea ...... ive on patterns and predictors
@en
P2093
Diane Herbeck
P2860
P356
10.1016/J.DRUGALCDEP.2014.02.702
P577
2014-03-12T00:00:00Z